Clinical Trial Update: Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of gemcitabine and irinotecan in locally advanced or metastatic bladder cancer; the study was terminated and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Gemzar (gemcitabine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Bladder Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-07-12